NFKB1 and neoplasm: Consistent with the cellular data, Alp treatment also restored the decreased PPAR-γ expression levels and inhibited STAT3 and NF-κB phosphorylation in gastrocnemius muscles of LLC tumor–bearing mice as shown by the Western blot (Figure 3D).